Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.

Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.

Item
http://www.wikidata.org/entity/Q33585572
An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain.Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic painPregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.Efficacy and Safety of Pregabalin for the Treatment of Neuropathic Pain in Patients Undergoing Hemodialysis.Characteristics of Ocular Pain Complaints in Patients With Idiopathic Dry Eye Symptoms.Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan.An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia.
P2860

Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.

Item
http://www.wikidata.org/entity/Q33585572
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy and safety evaluation ...... lind placebo-controlled trial.
@ast
Efficacy and safety evaluation ...... lind placebo-controlled trial.
@en
Efficacy and safety evaluation ...... lind placebo-controlled trial.
@nl
type
label
Efficacy and safety evaluation ...... lind placebo-controlled trial.
@ast
Efficacy and safety evaluation ...... lind placebo-controlled trial.
@en
Efficacy and safety evaluation ...... lind placebo-controlled trial.
@nl
prefLabel
Efficacy and safety evaluation ...... lind placebo-controlled trial.
@ast
Efficacy and safety evaluation ...... lind placebo-controlled trial.
@en
Efficacy and safety evaluation ...... lind placebo-controlled trial.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Efficacy and safety evaluation ...... lind placebo-controlled trial.
@en
P2093
P2860
P304
P31
P356
10.1111/J.2040-1124.2011.00122.X
P433
P478
P577
P5875
P698
P921
P932